Dacotin 100 mg Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Dacotin 100 mg Injection contains oxaliplatin, a platinum-based cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of cancer of the colon and rectum. It is given into the veins by a qualified doctor, in the interval, amount, and duration the doctor sees fit, depending on the patient’s condition and progress. It is described as damaging the genetic material of cancer cells, which stops or slows their growth and multiplication.

Active ingredient
Oxaliplatin
Strength
100 mg
Dosage form
Concentrate / powder for solution for infusion
Therapeutic class
Platinum-based alkylating agent (antineoplastic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of cancer of the colon and rectum
  • Described as stopping or slowing the growth of cancer cells
  • Described as damaging the genetic material of cancer cells to stop their growth and multiplication
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Given into the veins by a qualified doctor only
  • The interval, amount, and duration are decided by the doctor, depending on the patient’s condition and progress
  • Regular blood tests for monitoring blood cells, heart condition, liver, and blood uric acid levels may be carried out

Described Side Effects

Commonly described side effects include:

  • Abdominal pain
  • Injection site reaction
  • Weight gain
  • Fever and nosebleeds
  • Hair loss
  • Constipation
  • Decreased appetite
  • Infection
  • Pain and taste change
  • Allergic reaction
  • Fatigue
  • Nausea, vomiting, and diarrhoea
  • Anaemia and low blood platelets
  • Headache and breathlessness

These are described as commonly temporary. The doctor should be informed at once if they persist or are bothersome.

Precautions

  • A complete medical history should be shared, with the doctor informed of heart disease or liver or kidney issues
  • Not for pregnant or breastfeeding women; the doctor should be consulted first if a future pregnancy is planned, as it causes infertility
  • Driving should be avoided after taking the medicine, as it causes dizziness
  • Regular blood, heart, liver, and uric acid monitoring may be carried out

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains oxaliplatin and is used for the treatment of cancer of the colon and rectum. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as given into the veins by a qualified doctor only, in the interval, amount, and duration the doctor sees fit.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services